首页 › 基金 › Sofinnova Investments, Inc. › PHVS

Sofinnova Investments, Inc. 对 PHVS 的持仓历史

PHARVARIS N V · 医疗保健

Sofinnova Investments, Inc. 在 Q2 2026 的 13F 申报中披露持有 PHVS(PHARVARIS N V)881,299 股,市值约 US$30.5M,约占其申报组合的 1.62%,在其申报持仓中市值排名第 22 位。 Sofinnova Investments, Inc. 最近 11 个申报季度中有 11 个季度披露了 PHVS 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q2 2026)881.30K 股
申报持仓市值$30.48M
组合权重1.62%
首次申报Q4 2023
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Sofinnova Investments, Inc. 对 PHVS 的持仓演变

Sofinnova Investments, Inc. 于 Q4 2023 首次披露 PHVS 持仓:510,441 股(约 US$14.3M)。 该持仓在 Q2 2026 达到峰值 881,299 股,市值约 US$30.5M。 在 11 次申报中,Sofinnova Investments, Inc. 7 次增持、2 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 881,299 股、市值约 US$30.5M,环比增持 62,971 股。。 持仓曾出现大幅变动:Q3 2025 增持约 26% (随后一个季度股价上涨 11%)。

逐季持仓明细

季度股数金额变化
Q4 2023 510.44K $14.32M 新进
Q1 2024 584.67K $13.51M 增持
Q2 2024 601.53K $11.31M 增持
Q3 2024 600.30K $11.12M 持有
Q4 2024 560.72K $10.75M 减持
Q1 2025 593.40K $9.32M 增持
Q2 2025 585.53K $10.31M 减持
Q3 2025 739.88K $18.46M 增持
Q4 2025 745.17K $20.68M 增持
Q1 2026 818.33K $23.12M 增持
Q2 2026 881.30K $30.48M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PHVS 与 13F 数据

PHVS(PHARVARIS N V)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 PHVS,申报仓位最大的包括:GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PHVS 的基金

查看 PHVS 的全部基金持有人 →

常见问题

How long has Sofinnova Investments, Inc. held PHVS?

Sofinnova Investments, Inc. has disclosed PHVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Sofinnova Investments, Inc.'s current position in PHVS?

As of Q2 2026, Sofinnova Investments, Inc. holds 881.30K shares of PHVS (PHARVARIS N V), valued at $30.48M, representing 1.62% of its reported portfolio and ranking #22.

Has Sofinnova Investments, Inc. been buying or selling PHVS?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. increased its position in PHVS. The position peaked in Q2 2026 at 881.30K shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.